Occudo Quantitative Strategies LP Eli Lilly & CO Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $865,128 - $985,904	-2,918 Reduced 52.59%	2,631 $851,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $902,527 - $1.06 Million	3,238 Added 140.11%	5,549 $1.8 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $3.37 Million - $4.19 Million	-14,369 Reduced 86.15%	2,311 $662,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $337,949 - $419,397	-1,503 Reduced 8.27%	16,680 $4.61 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $4.03 Million - $4.96 Million	18,183 New	18,183 $4.2 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $209,438 - $270,906	-1,160 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $190,611 - $246,755	1,160 New	1,160 $217,000

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.